Top

Published in:

01-04-2015 | Gynecologic Endocrinology and Reproductive Medicine

Serum levels of fetuin A are increased in women with gestational diabetes mellitus

Authors: Ozlem Turhan Iyidir, Ceyla Konca Degertekin, Banu Aktas Yilmaz, Alev E. Altinova, Fusun B. Toruner, Nuray Bozkurt, Goksun Ayvaz, Mujde Akturk

Published in: Archives of Gynecology and Obstetrics | Issue 4/2015

Abstract

Purpose

Fetuin A is associated with insulin resistance and type 2 diabetes mellitus (DM). We aimed to investigate circulating fetuin A concentrations in gestational diabetes mellitus (GDM).

Methods

Serum fetuin A levels were studied in 26 pregnant women with GDM and 24 healthy pregnant women between 24th and 28th gestational weeks. Fetuin A levels were also evaluated in 18 of women with GDM at postpartum.

Results

Fetuin A concentrations were significantly increased in women with GDM compared to healthy pregnant women (35.0 ± 3.2 vs. 32.0 ± 4.4 ng/ml; p = 0.01). Also, fetuin A levels in women with GDM significantly decreased at postpartum period (35.0 ± 3.2 vs. 31.7 ± 3.9 ng/ml; p = 0.001). In whole pregnant women, there were positive correlations between fetuin A and HbA1c (r = 0.418, p = 0.002), total cholesterol (r = 0.332, p = 0.018) and triglycerides (r = 0.306, p = 0.031). Multivariate regression analysis demonstrated that HbA1c was the important predictor of circulating fetuin A level (beta = 0.375, p = 0.01).

Conclusion

In conclusion, our results indicate that serum fetuin A concentrations are increased in women with GDM and decreased after delivery. Therefore, fetuin A might have a role in the development of insulin resistance and the metabolic changes in GDM.

Arnaud P, Miribel L, Emerson DL (1988) Alpha 2-HS glycoprotein. Methods Enzymol 163:431–441CrossRefPubMed

Mori K, Emoto M, Inaba M (2011) Fetuin-A: a multifunctional protein. Recent Pat Endocr Metab Immune Drug Discov 5(2):124–146CrossRefPubMed

Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Krober SM, Machicao F, Fritsche A, Haring HU (2006) Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29(4):853–857CrossRefPubMed

Enli Y, Fenkci SM, Fenkci V, Oztekin O (2013) Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome. Gynecol Endocrinol 29(12):1036–1039. doi:10.3109/09513590.2013.829442 CrossRefPubMed

Ou HY, Yang YC, Wu HT, Wu JS, Lu FH, Chang CJ (2011) Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes. Clin Endocrinol 75(4):450–455. doi:10.1111/j.1365-2265.2011.04070.x CrossRef

Singh M, Sharma PK, Garg VK, Mondal SC, Singh AK, Kumar N (2012) Role of fetuin-A in atherosclerosis associated with diabetic patients. J Pharm Pharmacol 64(12):1703–1708. doi:10.1111/j.2042-7158.2012.01561.x CrossRefPubMed

Song A, Xu M, Bi Y, Xu Y, Huang Y, Li M, Wang T, Wu Y, Liu Y, Li X, Chen Y, Wang W, Ning G (2011) Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adults. PLoS One 6(4):e19228. doi:10.1371/journal.pone.0019228 CrossRefPubMedCentralPubMed

Sun Q, Cornelis MC, Manson JE, Hu FB (2013) Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the US. Diabetes 62(1):49–55. doi:10.2337/db12-0372 CrossRefPubMedCentralPubMed

Mathews ST, Chellam N, Srinivas PR, Cintron VJ, Leon MA, Goustin AS, Grunberger G (2000) Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol 164(1–2):87–98CrossRefPubMed

10.

Catalano PM (2014) Trying to understand gestational diabetes. Diabet Med 31(3):273–281. doi:10.1111/dme.12381 CrossRefPubMedCentralPubMed

11.

Huopio H, Cederberg H, Vangipurapu J, Hakkarainen H, Paakkonen M, Kuulasmaa T, Heinonen S, Laakso M (2013) Association of risk variants for type 2 diabetes and hyperglycemia with gestational diabetes. Eur J Endocrinol 169(3):291–297. doi:10.1530/EJE-13-0286 CrossRefPubMed

12.

Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25(10):1862–1868CrossRefPubMed

13.

Barbour LA, McCurdy CE, Hernandez TL, Friedman JE (2011) Chronically increased S6K1 is associated with impaired IRS1 signaling in skeletal muscle of GDM women with impaired glucose tolerance postpartum. J Clin Endocrinol Meta 96(5):1431–1441. doi:10.1210/jc.2010-2116 CrossRef

14.

Kalabay L, Cseh K, Pajor A, Baranyi E, Csakany GM, Melczer Z, Speer G, Kovacs M, Siller G, Karadi I, Winkler G (2002) Correlation of maternal serum fetuin/alpha2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes. Eur J Endocrinol 147(2):243–248CrossRefPubMed

15.

Farhan S, Handisurya A, Todoric J, Tura A, Pacini G, Wagner O, Klein K, Jarai R, Huber K, Kautzky-Willer A (2012) Fetuin-A characteristics during and after pregnancy: result from a case control pilot study. Int J Endocrinol 2012:896736. doi:10.1155/2012/896736 CrossRefPubMedCentralPubMed

16.

Coustan DR, Carpenter MW (1998) The diagnosis of gestational diabetes. Diabetes Care 21(Suppl 2):B5–B8PubMed

17.

Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499–502PubMed

18.

Denecke B, Graber S, Schafer C, Heiss A, Woltje M, Jahnen-Dechent W (2003) Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. Biochem J 376(Pt 1):135–145. doi:10.1042/BJ20030676 CrossRefPubMedCentralPubMed

19.

Olivier E, Soury E, Ruminy P, Husson A, Parmentier F, Daveau M, Salier JP (2000) Fetuin-B, a second member of the fetuin family in mammals. Biochem J 350(Pt 2):589–597CrossRefPubMedCentralPubMed

20.

Briana DD, Boutsikou M, Gourgiotis D, Boutsikou T, Baka S, Marmarinos A, Hassiakos D, Malamitsi-Puchner A (2008) Serum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth. J Matern Fetal Neonatal Med 21(11):826–830. doi:10.1080/14767050802326255 CrossRefPubMed

21.

Gunduz FO, Yildirmak ST, Temizel M, Faki Y, Cakmak M, Durmuscan M, Sezgin F (2011) Serum visfatin and fetuin-a levels and glycemic control in patients with obese type 2 diabetes mellitus. Diabetes Metab J 35(5):523–528. doi:10.4093/dmj.2011.35.5.523 CrossRefPubMedCentralPubMed

22.

Erdmann J, Salmhofer H, Knauss A, Mayr M, Wagenpfeil S, Sypchenko O, Luppa P, Schusdziarra V (2012) Relationship of fetuin-A levels to weight-dependent insulin resistance and type 2 diabetes mellitus. Regul Pept 178(1–3):6–10. doi:10.1016/j.regpep.2012.02.004 CrossRefPubMed

23.

Liu Y, Xu M, Xu Y, Li M, Wang T, Chen Y, Bi Y (2012) Positive correlation between chronic hyperglycemia and serum fetuin-A levels in middle-aged and elderly Chinese. J Diabetes 4(4):351–358. doi:10.1111/1753-0407.12000 CrossRefPubMed

24.

Ozyazgan S, Karaoglu K, Kurt A, Altinok A, Konukoglu D, Osar Siva Z, Andican G (2013) Effects of omega-3 polyunsaturated fatty acid supplementation on serum fetuin-A levels in type 2 diabetic patients. Minerva Med 104(3):287–293PubMed

25.

Jung CH, Kim BY, Kim CH, Kang SK, Jung SH, Mok JO (2013) Associations of serum fetuin-A levels with insulin resistance and vascular complications in patients with type 2 diabetes. Diab Vasc Dis Res 10(5):459–467. doi:10.1177/1479164113490766 CrossRefPubMed

26.

Stefan N, Haring HU (2013) Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans. Nat Med 19(4):394–395. doi:10.1038/nm.3116 CrossRefPubMed

27.

Pal D, Dasgupta S, Kundu R, Maitra S, Das G, Mukhopadhyay S, Ray S, Majumdar SS, Bhattacharya S (2012) Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med 18(8):1279–1285. doi:10.1038/nm.2851 CrossRefPubMed

Title: Serum levels of fetuin A are increased in women with gestational diabetes mellitus
Authors: Ozlem Turhan Iyidir
Ceyla Konca Degertekin
Banu Aktas Yilmaz
Alev E. Altinova
Fusun B. Toruner
Nuray Bozkurt
Goksun Ayvaz
Mujde Akturk
Publication date: 01-04-2015
Publisher: Springer Berlin Heidelberg
Published in: Archives of Gynecology and Obstetrics / Issue 4/2015
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-014-3490-3

At a glance: The STEP trials

Springer Medicine

Serum levels of fetuin A are increased in women with gestational diabetes mellitus

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2015

Minimally invasive surgery for endometrial cancer: a comprehensive review

Emergency peripartum hysterectomy in a tertiary teaching hospital: a 14-year review

Surgical and systemic management of endometrial cancer: an international survey

Predictors of success of laparoscopic ovarian drilling in women with polycystic ovary syndrome: an evidence-based approach

Effectiveness of expectant management versus methotrexate in tubal ectopic pregnancy: a double-blind randomized trial

Response to: Predictors of success of laparoscopic ovarian drilling in women with polycystic ovary syndrome; an evidence-based approach